Detalhe da pesquisa
1.
Low immunogenicity of tocilizumab in patients with rheumatoid arthritis.
Ann Rheum Dis
; 76(6): 1078-1085, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28007755
2.
2017 White Paper on recent issues in bioanalysis: a global perspective on immunogenicity guidelines & biomarker assay performance (Part 3 - LBA: immunogenicity, biomarkers and PK assays).
Bioanalysis
; 9(24): 1967-1996, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29205064
3.
Validation of a ligand-binding assay for active protein drug quantification following the 'free analyte QC concept'.
Bioanalysis
; 8(24): 2537-2549, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27807984
4.
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3 - LBA, biomarkers and immunogenicity).
Bioanalysis
; 8(23): 2475-2496, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27855512
5.
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3--LBA, biomarkers and immunogenicity).
Bioanalysis
; 7(24): 3107-24, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26635247
6.
Singlicate analysis in regulated bioanalysis using ligand-binding assays: where are we heading?
Bioanalysis
; 9(18): 1357-1359, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28920450
7.
Subset analysis of patients experiencing clinical events of a potentially immunogenic nature in the pivotal clinical trials of tocilizumab for rheumatoid arthritis: Evaluation of an antidrug antibody ELISA using clinical adverse event-driven immunogenicity testing.
Clin Ther
; 32(9): 1597-609, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20974317
8.
Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models.
Anticancer Drugs
; 15(5): 503-12, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15166626